§ Funding Round
Series A funding round for Lysosomal Therapeutics raising $20M in February 2015
Series A funding round for Lysosomal Therapeutics raising $20M in February 2015
| Investor | Firm Type | Partner |
|---|---|---|
Advent Life Sciences | — | — |
Apollo Health Ventures | — | — |
| Organization | — | |
Atlas VentureLEAD | Organization | — |
| Organization | — | |
Omega Funds | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | bob carpenter | |
| Angel | henri termeer | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Roche | — | — |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$25M
Top Valuation
-
Lysosomal Therapeutics raised $20M in a Series A round.
The round was announced on 02/01/15.
The round was led by Atlas Venture.
